CCNB1 and hepatocellular carcinoma: Liu et al. further identified 368 DEGs and 10 hub genes as potential diagnostic biomarkers and therapeutic targets for HCV-related HCC, highlighting CCNB1, KIF20A, and HMMR as candidate targets for diagnosis and therapy [40].